New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp
Oncology January 26,2024
Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp
Oncology January 26,2024
Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

byNorthwestern UniversityCredit: Unsplash/CC0 Public DomainMost patients with type 2 diabetes will end up needing to add a second-line medication after metformin—the go-to primary drug for gluco
Breakthroughs January 26,2024
Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

byNorthwestern UniversityCredit: Unsplash/CC0 Public DomainMost patients with type 2 diabetes will end up needing to add a second-line medication after metformin—the go-to primary drug for gluco
Breakthroughs January 26,2024
New hybrid treatment forces cancer cells to starve

New hybrid treatment forces cancer cells to starve

by Greg Williams,NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.The wor
Oncology January 26,2024
New hybrid treatment forces cancer cells to starve

New hybrid treatment forces cancer cells to starve

by Greg Williams,NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.The wor
Oncology January 26,2024
Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue
Oncology January 26,2024
Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue
Oncology January 26,2024
Ozempic mania's billions in bills are coming for US taxpayers

Ozempic mania's billions in bills are coming for US taxpayers

by Simone Foxman, Laura Nahmias, Bloomberg NewsCredit: Markus Winkler from PexelsState and local governments across the US are grappling with a growing problem: Expensive drugs to treat diabetes and o
Breakthroughs January 26,2024
Ozempic mania's billions in bills are coming for US taxpayers

Ozempic mania's billions in bills are coming for US taxpayers

by Simone Foxman, Laura Nahmias, Bloomberg NewsCredit: Markus Winkler from PexelsState and local governments across the US are grappling with a growing problem: Expensive drugs to treat diabetes and o
Breakthroughs January 26,2024
Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?

Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?

by Alvin Powell, Harvard GazetteScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDThe Food and Drug Administration&nbs
Q & A January 26,2024
Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?

Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?

by Alvin Powell, Harvard GazetteScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDThe Food and Drug Administration&nbs
Q & A January 26,2024
Scientists find new, better way to develop vaccines

Scientists find new, better way to develop vaccines

byOxford University PressCredit: CC0 Public DomainAnew paperinBiology Methods & Protocolsindicates that researchers in Germany have developed a new system to display
Public Health & Prevention January 26,2024
Scientists find new, better way to develop vaccines

Scientists find new, better way to develop vaccines

byOxford University PressCredit: CC0 Public DomainAnew paperinBiology Methods & Protocolsindicates that researchers in Germany have developed a new system to display
Public Health & Prevention January 26,2024
Calcium channel blockers key to reversing myotonic dystrophy muscle weakness, study finds

Calcium channel blockers key to reversing myotonic dystrophy muscle weakness, study finds

byUniversity of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainNew research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy
Breakthroughs January 26,2024
Calcium channel blockers key to reversing myotonic dystrophy muscle weakness, study finds

Calcium channel blockers key to reversing myotonic dystrophy muscle weakness, study finds

byUniversity of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainNew research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy
Breakthroughs January 26,2024
New antibiotic slays deadly superbug in early trial

New antibiotic slays deadly superbug in early trial

by Robin FosterResearchers report that a new type of antibiotic has proved its mettle against a deadly superbug.Acinetobacter baumannii, abacteriathat goes by the nickname CRAB when it bec
Breakthroughs January 26,2024
New antibiotic slays deadly superbug in early trial

New antibiotic slays deadly superbug in early trial

by Robin FosterResearchers report that a new type of antibiotic has proved its mettle against a deadly superbug.Acinetobacter baumannii, abacteriathat goes by the nickname CRAB when it bec
Breakthroughs January 26,2024
New treatment options for advanced myelofibrosis and other blood malignancies show promise

New treatment options for advanced myelofibrosis and other blood malignancies show promise

byUniversity of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainFew standard treatments have been available for advanced myelofibrosis, a bone marrow disorder characterized by
Breakthroughs January 26,2024
New treatment options for advanced myelofibrosis and other blood malignancies show promise

New treatment options for advanced myelofibrosis and other blood malignancies show promise

byUniversity of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainFew standard treatments have been available for advanced myelofibrosis, a bone marrow disorder characterized by
Breakthroughs January 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com